XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash equivalents, at carrying value  
Payments to acquire marketable securities 2,744,338 3,431,414  
Proceeds from sale of marketable securities 3,790,000 2,145,000  
Marketable securities, gross realized (gain) loss 4,047 766  
Marketable securities, gross unrealized gain (loss) (6,250) 1,427  
Marketable securities $ 250,388 1,285,753  
Marketable securities maturity dates January 2, 2019 to January 31, 2019.    
Derivative, gain (loss) on derivative, net $ 250,241 $ (91,032)  
Measurement Input, Expected Dividend Rate [Member]      
Fair value measurements, input percentage 0.00%    
Private Placement [Member] | Series B Preferred Stock [Member]      
Class of warrant or right, issued     127,346
Private Placement [Member] | Placement Agent Warrants [Member] | Series B Preferred Stock [Member]      
Class of warrant or right, issued 127,346    
Private Placement [Member] | Debt Settlement [Member] | Series B Preferred Stock [Member] | Strategic Bio Partners [Member]      
Class of warrant or right, issued 295,945    
Equipment [Member]      
Property, plant and equipment, useful life 3 years